Page last updated: 2024-11-05

methylacetylene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methylacetylene: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6335
CHEMBL ID116902
CHEBI ID48086
MeSH IDM0077627

Synonyms (40)

Synonym
propyne
ccris 6830
brn 0878138
hsdb 2508
einecs 200-828-4
acetylene, methyl-
propylene tetramer
inchi=1/c3h4/c1-3-2/h1h,2h
prop-1-yne
1-propyne
methylacetylene
74-99-7
propyne, >=97%
propyne, >=99%
CHEBI:48086 ,
allylene
methyl acetylene
CHEMBL116902
P1881
mfcd00036235
AKOS009104530
086l40et1b ,
4-01-00-00958 (beilstein handbook reference)
unii-086l40et1b
propynylidyne
FT-0628850
1-propyne [hsdb]
ch3c.$.ch
P2295
P2152
DTXSID0026387 ,
J-802281
propyne, 99%
7299-37-8
Q3407647
Q151446
28391-48-2
propyne (ca. 5% in tetrahydrofuran, ca. 1 mol/l)
methylacetylene-d1
dtxcid406387
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
alkyneAcyclic branched or unbranched hydrocarbons having a carbon-carbon triple bond and the general formula CnH2n-2, RC#CR.
terminal acetylenic compoundAn acetylenic compound which a carbon of the C#C moiety is attached to a hydrogen atom.
gas molecular entityAny main group molecular entity that is gaseous at standard temperature and pressure (STP; 0degreeC and 100 kPa).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
acetylene degradation121

Bioassays (1)

Assay IDTitleYearJournalArticle
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (55)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (14.55)18.7374
1990's8 (14.55)18.2507
2000's23 (41.82)29.6817
2010's12 (21.82)24.3611
2020's4 (7.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.90 (24.57)
Research Supply Index4.04 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index84.24 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (53.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (5.36%)6.00%
Case Studies1 (1.79%)4.05%
Observational0 (0.00%)0.25%
Other52 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]